Medizinische Universität Graz - Research portal
Schulz Eduard |
** = Publications listed in SCI/SSCI/Pubmed
2025
Full paper/article (Journal)
** El, Jurdi, N; Holtzman, NG; Hishmeh, R; Mina, A; Schulz, E; Stokes, A; Li, G; Schmidt, KT; Figg, WD; Micheletti, N; Mays, JW; Cowen, EW; Pavletic, SZ; Pusic, I
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned.
Br J Haematol. 2025;
Doi: 10.1111/bjh.20069
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Curtis, LM; Holtzman, NG; Sponaugle, J; Wloka, K; Ostojic, A; Mina, A; El, Jurdi, N; Pirsl, F; Carpenter, A; Golagha, M; Sirajuddin, A; Heller, T; Shaffer, BC; Hakim, FT; Rubin, JS; Gress, RE; Pavletic, SZ
Phase 1/2 Study of High-Dose Palifermin for GVHD Prophylaxis in Patients Undergoing HLA-Matched Unrelated Donor HCT.
Blood. 2025;
Doi: 10.1182/blood.2024028303
PubMed
FullText
FullText_MUG
Short report/Letter
** Schulz, E; Pirsl, F; McGraw, K; Nousome, D; Liu, Y; Goklemez, S; Mina, A; Holtzman, NG; El, Jurdi, N; Pavletic, SZ
Prevalence of clonal hematopoiesis of indeterminate potential in patients with severe chronic graft-versus-host disease.
Bone Marrow Transplant. 2025;
Doi: 10.1038/s41409-025-02537-x
Web of Science
PubMed
FullText
FullText_MUG
2024
Full paper/article (Journal)
** Czech, MM; Schulz, E; Mina, A; Gea-Banacloche, J
Infections and antimicrobial prophylaxis in patients with myelodysplastic syndromes.
Semin Hematol. 2024;
Doi: 10.1053/j.seminhematol.2024.07.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Holtzman, NG; Curtis, LM; Salit, RB; Shaffer, BC; Pirsl, F; Ostojic, A; Steinberg, SM; Schulz, E; Wilder, JS; Hughes, TE; Rose, J; Memon, S; Korngold, R; Gea-Banacloche, JC; Fowler, DH; Hakim, FT; Gress, RE; Bishop, MR; Pavletic, SZ
High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention.
Blood Adv. 2024; 8(16):4294-4310
Doi: 10.1182/bloodadvances.2023010973
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Wölfler, A; Reisinger, AC; Reinisch, A; Eller, P; Eisner, F; Kreuzer, P; Stradner, M; Rosenkranz, AR; Krammer, F; Schilcher, G; Krause, R; Hatzl, S
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Crit Care Explor. 2024; 6(2): e1046
Doi: 10.1097/CCE.0000000000001046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Pavletic, SZ; Mina, A
Allogeneic hematopoietic cell transplantation in elderly patients with myelodysplastic syndromes: Considerations and challenges.
Semin Hematol. 2024;
Doi: 10.1053/j.seminhematol.2024.10.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Pirsl, F; Holtzman, NG; Beshensky, D; Cowen, EW; Mitchell, SA; Steinberg, SM; Pavletic, SZ
Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.
Haematologica. 2023;
Doi: 10.3324/haematol.2023.283646
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Gavrilova, T; Schulz, E; Mina, A
Breaking Boundaries: Immunotherapy for Myeloid Malignancies.
Cancers (Basel). 2024; 16(16):
Doi: 10.3390/cancers16162780
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Full paper/article (Journal)
** Beshensky, D; Pirsl, F; Holtzman, NG; Steinberg, SM; Mays, JW; Cowen, EW; Comis, LE; Joe, GO; Magone, MT; Schulz, E; Waldman, MA; Pavletic, SZ
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease.
Bone Marrow Transplant. 2023; 58(10):1112-1120
Doi: 10.1038/s41409-023-02032-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103
Doi: 10.1016/j.micinf.2023.105103
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Aplan, PD; Freeman, SD; Pavletic, SZ
Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes.
Blood Adv. 2023; 7(16):4381-4394
Doi: 10.1182/bloodadvances.2023010098
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zhao, AT; Pirsl, F; Steinberg, SM; Holtzman, NG; Schulz, E; Mina, A; Mays, JW; Cowen, EW; Comis, LE; Joe, GO; Yanovski, JA; Pavletic, SZ
Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease.
Bone Marrow Transplant. 2023; 58(12):1377-1383
Doi: 10.1038/s41409-023-02097-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S
Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5):
[Oral Communication]
Web of Science
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND.
[Poster]
Web of Science
2022
Full paper/article (Journal)
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Kraßnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.
Open Forum Infect Dis. 2022; 9(8): ofac393
Doi: 10.1093/ofid/ofac393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Review
** Neumeister, P; Schulz, E; Pansy, K; Szmyra, M; Deutsch, AJ
Targeting the Microenvironment for Treating Multiple Myeloma.
Int J Mol Sci. 2022; 23(14): 7627
Doi: 10.3390/ijms23147627
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2021
Full paper/article (Journal)
** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621
Doi: 10.1097/HS9.0000000000000621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207
Doi: 10.1007/s00520-021-06059-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hoenigl, M; Egger, M; Boyer, J; Schulz, E; Prattes, J; Jenks, JD
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study.
Mycoses. 2021; 64(10):1197-1202
Doi: 10.1111/myc.13352
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742
Doi: 10.3389/fimmu.2021.803742
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Halwachs, B; Bayer, N; Huber-Krassnitzer, B; Schulz, E; Uhl, B; Gaksch, L; Hatzl, S; Bachmayr, V; Kleissl, L; Kump, P; Deutsch, A; Stary, G; Greinix, H; Gorkiewicz, G; Högenauer, C; Neumeister, P
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Ther Adv Hematol. 2021; 12:20406207211058333
Doi: 10.1177/20406207211058333
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Zurl, C; Hoenigl, M; Schulz, E; Hatzl, S; Gorkiewicz, G; Krause, R; Eller, P; Prattes, J
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy.
J Fungi (Basel). 2021; 7(2):
Doi: 10.3390/jof7020088
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Comment
** Schulz, E
Convalescent Plasma for Outpatients with Covid-19.
N Engl J Med. 2021;
Doi: 10.1056/NEJMc2114591
Web of Science
PubMed
FullText
FullText_MUG
2020
Short report/Letter
** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833
Doi: 10.1007/s12253-020-00864-6
Web of Science
PubMed
FullText
FullText_MUG
Comment
** Hatzl, S; Eisner, F; Schilcher, G; Kreuzer, P; Gornicec, M; Eller, P; Brodmann, M; Schlenke, P; Stradner, MH; Krause, R; Greinix, H; Schulz, E
Response to "COVID-19 in persons with haematological cancers".
Leukemia. 2020; 34(8):2265-2270
Doi: 10.1038/s41375-020-0914-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Case Report
** Hatzl, S; Greinix, HT; Kreuzer, P; Schulz, E; Neumeister, P; Scherr, D
A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report
MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271.
Doi: 10.1007/s12254-019-0514-5
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
2018
Short report/Letter
** Schulz, E; Lind, K; Renner, W; Petersen, BS; Quehenberger, F; Dill, C; Hofer, S; Lal, R; Hoefler, G; Schlenke, P; Ehninger, G; Schetelig, J; Middeke, JM; Stölzel, F; Sill, H
The TP53 Pro72Arg SNP in de novo acute myeloid leukaemia - results of two cohort studies involving 215 patients and 3759 controls.
Br J Haematol. 2018; 181(1):148-151
Doi: 10.1111/bjh.14527
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Full paper/article (Journal)
** Lal, R; Lind, K; Heitzer, E; Ulz, P; Aubell, K; Kashofer, K; Middeke, JM; Thiede, C; Schulz, E; Rosenberger, A; Hofer, S; Feilhauer, B; Rinner, B; Svendova, V; Schimek, MG; Rücker, FG; Hoefler, G; Döhner, K; Zebisch, A; Wölfler, A; Sill, H
Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia.
Blood. 2017; 129(18): 2587-2591.
Doi: 10.1182/blood-2016-11-751008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Schulz, E; Sill, H
The TP53 Pro72Arg SNP in de novo acute myeloid leukemia.
Haematologica. 2017; 102(5): e214-e215-e214-e215.
Doi: 10.3324/haematol.2017.165019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Schulz, E; Uhl, B; Kashofer, K; Aigelsreiter, A; Zinke-Cerwenka, W; Mulabecirovic, A; Kump, PK; Halwachs, B; Gorkiewicz, G; Sill, H; Greinix, H; Högenauer, C; Neumeister, P
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Haematologica. 2017; 102(5):e210-e213-e210-e213
Doi: 10.3324/haematol.2016.154351
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Neumeister, P; Spindelboeck, W; Zinke-Cerwenka, W; Schulz, E; Hoegenauer, C; Sill, H; Gorkiewicz, G; Kump, P; Greinix, H
Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2017; 52: S232-S232.
Web of Science
2016
Abstract (Journal)
** Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Rankl, J; Hofer, S; Mueller, M; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
IMPAIRED BASE EXCISION REPAIR GLYCOSYLASE/AP ENDONUCLEASE ACTIVITY CONTRIBUTES TO CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA
HAEMATOLOGICA. 2016; 101: 211-212.
[Poster]
Web of Science
** Schulz, E; Lind, K; Renner, W; Petersen, BS; Dill, C; Hofer, S; Lal, R; Quehenberger, F; Stolzel, F; Sill, H
THE HOMOZYGOUS TP53 P72R SNP IS ASSOCIATED WITH NON-FAVORABLE CYTOGENETIC RISK GROUPS IN ACUTE MYELOID LEUKEMIA
HAEMATOLOGICA. 2016; 101: 383-383.
[Poster]
Web of Science
Comment
** Sill, H; Schulz, E; Steinke-Lange, V; Boland, CR
Correspondence: Reply to 'SEMA4A variation and risk of colorectal cancer'.
Nat Commun. 2016; 7:10695-10695
Doi: 10.1038/ncomms10695
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Full paper/article (Journal)
** Lin, AP; Abbas, S; Kim, SW; Ortega, M; Bouamar, H; Escobedo, Y; Varadarajan, P; Qin, Y; Sudderth, J; Schulz, E; Deutsch, A; Mohan, S; Ulz, P; Neumeister, P; Rakheja, D; Gao, X; Hinck, A; Weintraub, ST; DeBerardinis, RJ; Sill, H; Dahia, PL; Aguiar, RC
D2HGDH regulates alpha-ketoglutarate levels and dioxygenase function by modulating IDH2.
Nat Commun. 2015; 6(7):7768-7768
Doi: 10.1038/ncomms8768
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Schulz, E; Kashofer, K; Heitzer, E; Mhatre, KN; Speicher, MR; Hoefler, G; Sill, H
Preexisting TP53 mutation in therapy-related acute myeloid leukemia.
Ann Hematol. 2015; 94(3):527-529
Doi: 10.1007/s00277-014-2191-0
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zebisch, A; Schulz, E; Grosso, M; Lombardo, B; Acierno, G; Sill, H; Iolascon, A
Identification of a novel variant of epsilon-gamma-delta-beta thalassemia highlights limitations of next generation sequencing.
Am J Hematol. 2015; 90(3): E52-E54.
Doi: 10.1002/ajh.23913
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Full paper/article (Journal)
** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Nojima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Heitzer, E; Geigl, JB; Windpassinger, C; Hoefler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H
Germline variants in the SEMA4A gene predispose to familial colorectal cancer type X.
Nat Commun. 2014; 5(10):5191-5191
Doi: 10.1038/ncomms6191
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Woelfler, A; Zebisch, A; Sill, H
Base Excision Repair Glycosylase Activity Is Impaired in a Subgroup of Acute Myeloid Leukemia Resulting in Increased Levels of Oxidative Base Lesions
BLOOD. 2014; 124(21):-56th Annual Meeting of the American-Society-of-Hematology; DEC 06-09, 2014; San Francisco, CA.
[Poster]
Web of Science
** Olipitz, W; Lind, K; Monsberger, N; Katschnig, A; Mangerich, A; Hofer, S; Schulz, E; Quehenberger, F; Schlembach, D; Robier, C; Wölfler, A; Zebisch, A; Sill, H
Base excision repair glycosylase activity is impaired in a subgroup of acute myeloid leukemia resulting in increased levels of oxidative base lesions
Oncol Res Treat. 2014; 37(S5):49-49.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Poster]
Web of Science
** Schulz, E; Kashofer, K; Mhatre, KN; Höfler, G; Sill, H
SELECTION OF A PRE-EXISTING TP53 MUTATED CLONE IN THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Haematologica. 2014; 99(S1):15-15.-19th Congress of the European Hematology Association; JUNE 12-15, 2014; Milan, ITALY.
[Poster]
Web of Science
FullText
** Schulz, E; Klampfl, P; Holzapfel, S; Janecke, AR; Ulz, P; Renner, W; Kashofer, K; Najima, S; Leitner, A; Zebisch, A; Wölfler, A; Hofer, S; Gerger, A; Lax, S; Beham-Schmid, C; Steinke, V; Geigl, JB; Höfler, G; Speicher, MR; Boland, CR; Kumanogoh, A; Sill, H
Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X
Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
[Oral Communication]
Web of Science
2012
Full paper/article (Journal)
** Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wölfler, A; Zebisch, A; Olipitz, W; Geigl, J; Berghold, A; Speicher, MR; Sill, H
Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms.
J Med Genet. 2012; 49(7):422-428
Doi: 10.1136/jmedgenet-2011-100674
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Schulz, E; Valentin, A; Ulz, P; Beham-Schmid, C; Lind, K; Rupp, V; Lackner, H; Wolfler, A; Zebisch, A; Olipitz, W; Geigl, JB; Berghold, A; Speicher, MR; Sill, H
Germ-line mutations in cancer predisposing genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy-related myeloid neoplasms.
ONKOLOGIE. Onkologie. 2012; 35: 117-117.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 19-23, 2012; Stuttgart, GERMANY.
[Poster]
Web of Science
2011
Review
** Sill, H; Olipitz, W; Zebisch, A; Schulz, E; Wölfler, A
Therapy-related myeloid neoplasms: pathobiology and clinical characteristics.
Br J Pharmacol. 2011; 162(4): 792-805.
Doi: 10.1111/j.1476-5381.2010.01100.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG